- Home
- EONR vs BDRX Comparison
EONR vs BDRX Comparison
Compare EONR & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EONR
- BDRX
- Stock Information
- Founded
- EONR 2017
- BDRX 2000
- Country
- EONR United States
- BDRX United Kingdom
- Employees
- EONR N/A
- BDRX N/A
- Industry
- EONR
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- EONR
- BDRX Health Care
- Exchange
- EONR NYSE
- BDRX Nasdaq
- Market Cap
- EONR 6.8M
- BDRX 5.8M
- IPO Year
- EONR N/A
- BDRX N/A
- Fundamental
- Price
- EONR $0.38
- BDRX $0.87
- Analyst Decision
- EONR Strong Buy
- BDRX
- Analyst Count
- EONR 1
- BDRX 0
- Target Price
- EONR $2.00
- BDRX N/A
- AVG Volume (30 Days)
- EONR 14.9M
- BDRX 3.1M
- Earning Date
- EONR 08-15-2025
- BDRX 04-11-2025
- Dividend Yield
- EONR N/A
- BDRX N/A
- EPS Growth
- EONR N/A
- BDRX N/A
- EPS
- EONR N/A
- BDRX N/A
- Revenue
- EONR $19,638,616.00
- BDRX N/A
- Revenue This Year
- EONR $46.94
- BDRX N/A
- Revenue Next Year
- EONR $64.38
- BDRX N/A
- P/E Ratio
- EONR N/A
- BDRX N/A
- Revenue Growth
- EONR N/A
- BDRX N/A
- 52 Week Low
- EONR $0.33
- BDRX $0.78
- 52 Week High
- EONR $2.92
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- EONR N/A
- BDRX 38.67
- Support Level
- EONR N/A
- BDRX $0.85
- Resistance Level
- EONR N/A
- BDRX $0.92
- Average True Range (ATR)
- EONR 0.00
- BDRX 0.06
- MACD
- EONR 0.00
- BDRX 0.01
- Stochastic Oscillator
- EONR 0.00
- BDRX 32.73
About EONR EON RESOURCES INC
EON Resources Inc is an independent upstream energy company focused on maximizing total returns to its shareholders through the development of onshore oil and natural gas properties in the United States. Its current focus is as an upstream energy company producing oil and gas properties in the Permian Basin.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.